The independent source for health policy research, polling, and news.
August 25, 2022
In this column for the JAMA Forum, KFF’s Larry Levitt explores the Medicare drug-price negotiation provisions and other significant drug-price changes in the Inflation Reduction Act and their potential to lead to further efforts to address health care costs.
Guest Essay Read PostAugust 13, 2022
Larry Levitt writes about the political and practical impact of the health care provisions in the Inflation Reduction Act in The New York Times guest essay, “The Biggest Health Care Reform in a Decade Could Lower Your Costs.”
Guest Essay Read PostMay 19, 2022
In this column for the JAMA Health Forum, Larry Levitt highlights four changes implemented during the COVID-19 pandemic that helped to make health care more accessible and affordable and the prospects for those changes to telehealth, COVID-19 coverage, Medicaid and marketplace premiums continuing beyond the pandemic’s end.
Column Read PostMarch 31, 2022
KHN’s Céline Gounder and KFF’s Mollyann Brodie look at the challenges in returning to normal life after the COVID-19 pandemic when many Americans, particularly people of color and workers with low incomes, do not have paid sick leave.
Op-Ed Read PostJanuary 20, 2022
In this column for the JAMA Health Forum, Larry Levitt examines how the No Surprises Act that prohibits unexpected out-of-network charges for patients could lead to lower payment rates and revenues for some doctors and other care providers.
Column Read Post
February 4, 2022
Tracking The Pandemic’s Effects On Health Outcomes, Costs, And Access To Care
This Health Affairs Grantwatch article summarizes findings from several KFF-Peterson Health System Tracker analyses with an emphasis on the COVID-19 pandemic’s impact through 2021 and a look ahead toward 2022.
Commentary Read Post